Literature DB >> 1936030

Diagnosis of left atrial thrombi in mitral stenosis--usefulness of ultrasound techniques compared with other methods.

J Acar1, B Cormier, D Grimberg, G Kawthekar, B Iung, B Scheuer, E Farah.   

Abstract

The purpose of this study was to evaluate various methods of diagnosis of left atrial thrombi (LAT) in patients (pts) with mitral stenosis (MS). From 1980 to 1990, 581 pts with MS have undergone open mitral commissurotomy (n = 169) or valve replacement (n = 412). All pts had transthoracic 2D echocardiography (TTE), 101 transoesophageal echocardiography (TEE), 192 a left atrial angiography (A) (from a left ventricular injection if associated mitral regurgitation grade 3 (n = 154) or from an injection in the pulmonary artery (n = 38) and 229 a coronary angiography (CA). Tomodensitometry (TD), nuclear magnetic resonance (NMR) and 111 Indium platelet imaging (IPI) were performed in some cases, 2, 8 and 5 respectively. All these examinations were carried out in the month before surgery. LAT was found by the surgeon in 43 pts (7%). The site was left atrial appendage in 26 cases (60%) and left atrial cavity in 17 cases. Sensitivity (Se), specificity (Sp) of TTE/TEE/A/CA were the following: TTE, Se% 28, Sp% 99; TEE, Se% 83, Sp% 97; A, Se% 28, Sp% 99; CA, Se% 14, Sp% 100. Specificity was high with all methods but sensitivity was high only with TEE and poor with other methods because of difficulty in detecting thrombi of the left atrial appendage. Specificity and sensitivity of TD, NMR and IPI require more information. False-negative cases are possible with NMR (1 case) and IPI (1 case) in well established LAT. We conclude: TEE is the easiest way to detect LAT, particularly when located in the left atrial appendage. It should be carried out systematically before percutaneous mitral valvuloplasty or surgery.

Entities:  

Mesh:

Year:  1991        PMID: 1936030     DOI: 10.1093/eurheartj/12.suppl_b.70

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

1.  Intracardiac echocardiography for verification for left atrial appendage thrombus presence detected by transesophageal echocardiography: the ActionICE II study.

Authors:  Jakub Baran; Beata Zaborska; Roman Piotrowski; Malgorzata Sikora-Frąc; Ewa Pilichowska-Paszkiet; Piotr Kułakowski
Journal:  Clin Cardiol       Date:  2017-02-13       Impact factor: 2.882

2.  Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation.

Authors:  R M Heppell; K E Berkin; J M McLenachan; J A Davies
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

Review 3.  Role of Echocardiography in Assessment of Cardioembolic Sources: a Strong Diagnostic Resource in Patients with Ischemic Stroke.

Authors:  Luca Longobardo; Concetta Zito; Scipione Carerj; Giuseppe Caracciolo; Matt Umland; Bijoy K Khandheria
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

4.  Interobserver variability in the detection of spontaneous echo contrast, left atrial thrombi, and left atrial appendage thrombi by transoesophageal echocardiography.

Authors:  G Kronik; C Stöllberger; M Schuh; F Abzieher; J Slany; B Schneider
Journal:  Br Heart J       Date:  1995-07

Review 5.  Left Atrial Appendage Function and Stroke Risk.

Authors:  Shadi Yaghi; Christopher Song; William A Gray; Karen L Furie; Mitchell S V Elkind; Hooman Kamel
Journal:  Stroke       Date:  2015-10-27       Impact factor: 7.914

Review 6.  Cardiovascular magnetic resonance imaging for valvular heart disease.

Authors:  Angela Morello; Eli V Gelfand
Journal:  Curr Heart Fail Rep       Date:  2009-09

7.  A "Ping-Pong" left atrial thrombus mimicking left atrial myxoma: A case report.

Authors:  Erlangga Diasmara Hargiyanto; Ivana Purnama Dewi; Budi Baktijasa Dharmadjati
Journal:  Ann Med Surg (Lond)       Date:  2022-08-06

8.  Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure.

Authors:  Axel Brandes; Harry J G M Crijns; Michiel Rienstra; Paulus Kirchhof; Erik L Grove; Kenneth Bruun Pedersen; Isabelle C Van Gelder
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.